Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.23 - $10.44 $157,830 - $315,058
30,178 New
30,178 $164,000
Q3 2023

Nov 13, 2023

BUY
$3.77 - $6.23 $514,326 - $849,933
136,426 New
136,426 $527,000
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $533,169 - $863,771
95,550 New
95,550 $573,000
Q1 2022

May 13, 2022

SELL
$5.24 - $15.58 $76,257 - $226,735
-14,553 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $43,763 - $66,741
2,883 Added 24.7%
14,553 $225,000
Q3 2021

Nov 12, 2021

BUY
$16.29 - $25.88 $190,104 - $302,019
11,670 New
11,670 $263,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $325M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.